Annexon, Inc.

ANNX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $1.0B · 96 employees
114
SEC Filings
$4.67
Close 2026-09-08
96
Employees

Business Summary

Annexon, Inc. is a biopharmaceutical company developing targeted immunotherapies for complement-mediated neuroinflammatory diseases affecting nearly 10 million people worldwide. Its pipeline includes tanruprubart (anti-C1q antibody for Guillain-Barré Syndrome), vonaprument (intravitreal C1q inhibitor for geographic atrophy/dry AMD), ANX1502 (oral small molecule C1s inhibitor for autoimmune conditions), and ANX009 (subcutaneous C1q-blocking Fab for lupus nephritis). The company targets the classical complement pathway by blocking C1q, the initiating molecule, across autoimmune, neurodegeneration, and ophthalmology therapeutic areas.

Latest Stock Quote

ANNX 2026-09-08 $4.67 O:$4.76 H:$4.785 L:$4.64 Vol:2.1M VWAP:$4.7042
origin leaf: null

Next Earnings

expected 2026-11-11

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001193125-26-131782EDGAR83K words
2025-03-032024-12-310000950170-25-030849EDGAR82K words
2024-03-262023-12-310000950170-24-036408EDGAR93K words
2023-03-062022-12-310000950170-23-006232EDGAR82K words
2022-03-012021-12-310001564590-22-008044EDGAR—
2021-03-252020-12-310001564590-21-015262EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-122026-06-300001193125-26-346779EDGAR57K words
2025-11-102025-09-300001193125-25-274240EDGAR57K words
2025-08-142025-06-300000950170-25-108869EDGAR56K words
2025-05-122025-03-310000950170-25-069200EDGAR53K words
2024-11-142024-09-300000950170-24-127057EDGAR55K words
2024-08-122024-06-300000950170-24-095401EDGAR54K words
2024-05-132024-03-310000950170-24-058659EDGAR52K words
2023-11-132023-09-300000950170-23-062913EDGAR53K words
2023-08-072023-06-300000950170-23-039054EDGAR52K words
2023-05-082023-03-310000950170-23-018797EDGAR51K words
2022-11-032022-09-300000950170-22-021509EDGAR—
2022-08-082022-06-300000950170-22-015560EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-120001193125-26-345672EDGAR3K words
2026-08-100001193125-26-342524EDGAR1K words
2026-08-060001193125-26-336867EDGAR2K words
2026-07-300001193125-26-326199EDGAR1K words
2026-03-300001193125-26-131746EDGAR3K words
2026-02-170001193125-26-054695EDGAR1K words
2026-01-140001193125-26-012918EDGAR3K words
2026-01-120001193125-26-009740EDGAR2K words
2025-11-140001193125-25-283191EDGAR1K words
2025-11-100001193125-25-274220EDGAR3K words

114 total filings indexed. 86 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

autoimmune-diseases neurodegeneration ophthalmology rare/orphan-diseases neuromuscular-disorders classical-complement-pathway-inhibition c1q-targeting-platform biologics-license-application-(bla)-regulatory-pathway marketing-authorization-application-(maa)-regulatory-pathway

Company Identity

CIK0001528115
TickerANNX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.annexonbio.com
Listed2020-07-24

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 6de8eefb90fd05fd1c98865978f66bba073dc6cb7fd7bde16753cff9ca168b1b
parent: 7eca6f73d581ee522cb02edd4a5f0bdb55702e775cecc3b9c7b817fefcdb8aa2
content hash: c4d92274d46b43da5a457bc09f15ca4c8a60648eed19c3512e404a5e877a2e5c
signed: 2026-09-29T12:00:19.138Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ANNX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ANNX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ANNX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.